2018 CUA指南:男性下尿路症状/良性前列腺增生(更新版)

2018-10-12 加拿大泌尿外科协会 Can Urol Assoc J. 2018 Oct;12(10):303-312.

2018年10月,加拿大泌尿外科协会(CUA)更新发布了男性下尿路症状和良性前列腺增生指南,该指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。新版指南主要针对超过50岁的表现为下尿路症状以及良性前列腺肿大或增生的男性患者。

中文标题:

2018 CUA指南:男性下尿路症状/良性前列腺增生(更新版)

英文标题:

Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

发布机构:

加拿大泌尿外科协会

发布日期:

2018-10-12

简要介绍:

2018年10月,加拿大泌尿外科协会(CUA)更新发布了男性下尿路症状和良性前列腺增生指南,该指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。新版指南主要针对超过50岁的表现为下尿路症状以及良性前列腺肿大或增生的男性患者。 

拓展指南:前列腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 CUA指南:男性下尿路症状/良性前列腺增生(更新版))] GetToolGuiderByIdResponse(projectId=1, id=097ae1c00165a93c, title=2018 CUA指南:男性下尿路症状/良性前列腺增生(更新版), enTitle=Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update., guiderFrom=Can Urol Assoc J. 2018 Oct;12(10):303-312., authorId=null, author=, summary=2018年10月,加拿大泌尿外科协会(CUA)更新发布了男性下尿路症状和良性前列腺增生指南,该指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。新版指南主要针对超过50岁的表现为下尿路症状以及良性前列腺肿大或增生的男性患者。 , cover=, journalId=null, articlesId=null, associationId=1160, associationName=加拿大泌尿外科协会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Oct 12 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年10月,加拿大泌尿外科协会(CUA)更新发布了男性下尿路症状和良性前列腺增生指南,该指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。新版指南主要针对超过50岁的表现为下尿路症状以及良性前列腺肿大或增生的男性患者。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>前列腺</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=d16761c00165a695" title="2018 ASTRO指南:局限性前列腺癌大分割放射治疗(概要)" target=_blank>2018 ASTRO指南:局限性前列腺癌大分割放射治疗(概要)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=021671c0016a066b" title="中国前列腺癌患者基因检测专家共识(2018年版)" target=_blank>中国前列腺癌患者基因检测专家共识(2018年版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=10e541c001638978" title="2018 临床实践指南:前列腺特异性抗原(PSA)检测进行前列腺癌筛查" target=_blank>2018 临床实践指南:前列腺特异性抗原(PSA)检测进行前列腺癌筛查</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=72a581c001631297" title="NCCN临床实践指南:前列腺癌(2018.V4)" target=_blank>NCCN临床实践指南:前列腺癌(2018.V4)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=042631c0016269cd" title="2018 AUA指南:去势抵抗性前列腺癌(修订版)" target=_blank>2018 AUA指南:去势抵抗性前列腺癌(修订版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%89%8D%E5%88%97%E8%85%BA" target=_blank>有关前列腺更多指南</a></ul>, tagList=[TagDto(tagId=82055, tagName=男性下尿路症状), TagDto(tagId=34441, tagName=良性前列腺增生)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9055, appHits=455, showAppHits=7, pcHits=5550, showPcHits=4124, likes=117, shares=10, comments=5, approvalStatus=1, publishedTime=Wed Oct 24 21:43:51 CST 2018, publishedTimeString=2018-10-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Oct 24 21:43:51 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:48:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 CUA指南:男性下尿路症状/良性前列腺增生(更新版))])
2018 CUA指南:男性下尿路症状/良性前列腺增生(更新版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1221288, encodeId=2ee212212881a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=唐510, createdTime=Fri May 20 22:06:25 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052085, encodeId=c53310520852d, content=指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=沈敏, createdTime=Thu Sep 16 21:02:59 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051621, encodeId=f1b7105162164, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95c65601522, createdName=ms5000001277463367, createdTime=Wed Sep 15 20:31:38 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955647, encodeId=555d95564eeb, content=为什么打不开, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLn79ZwHAYZjc2yttkmYxTkbag3xDaOvPNXwV9ovaAhia6ADqKsvrb4H3psVQ7UyX4JROoian6aF2QA/132, createdBy=f73a2494319, createdName=qun5feiyang, createdTime=Sat Apr 10 10:26:41 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2022-05-20 唐510

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1221288, encodeId=2ee212212881a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=唐510, createdTime=Fri May 20 22:06:25 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052085, encodeId=c53310520852d, content=指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=沈敏, createdTime=Thu Sep 16 21:02:59 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051621, encodeId=f1b7105162164, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95c65601522, createdName=ms5000001277463367, createdTime=Wed Sep 15 20:31:38 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955647, encodeId=555d95564eeb, content=为什么打不开, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLn79ZwHAYZjc2yttkmYxTkbag3xDaOvPNXwV9ovaAhia6ADqKsvrb4H3psVQ7UyX4JROoian6aF2QA/132, createdBy=f73a2494319, createdName=qun5feiyang, createdTime=Sat Apr 10 10:26:41 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2021-09-16 沈敏

    指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1221288, encodeId=2ee212212881a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=唐510, createdTime=Fri May 20 22:06:25 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052085, encodeId=c53310520852d, content=指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=沈敏, createdTime=Thu Sep 16 21:02:59 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051621, encodeId=f1b7105162164, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95c65601522, createdName=ms5000001277463367, createdTime=Wed Sep 15 20:31:38 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955647, encodeId=555d95564eeb, content=为什么打不开, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLn79ZwHAYZjc2yttkmYxTkbag3xDaOvPNXwV9ovaAhia6ADqKsvrb4H3psVQ7UyX4JROoian6aF2QA/132, createdBy=f73a2494319, createdName=qun5feiyang, createdTime=Sat Apr 10 10:26:41 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1221288, encodeId=2ee212212881a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210322/61a71434e1764160b4cd9baee94e7a55/eee5c1c1e8a54e4bb58dbcf51dbb31f0.jpg, createdBy=eb4d1856368, createdName=唐510, createdTime=Fri May 20 22:06:25 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052085, encodeId=c53310520852d, content=指南是对2010版加拿大继发于良性前列腺增生的男性下尿路症状管理指南的更新。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=afe65591083, createdName=沈敏, createdTime=Thu Sep 16 21:02:59 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051621, encodeId=f1b7105162164, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95c65601522, createdName=ms5000001277463367, createdTime=Wed Sep 15 20:31:38 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955647, encodeId=555d95564eeb, content=为什么打不开, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLn79ZwHAYZjc2yttkmYxTkbag3xDaOvPNXwV9ovaAhia6ADqKsvrb4H3psVQ7UyX4JROoian6aF2QA/132, createdBy=f73a2494319, createdName=qun5feiyang, createdTime=Sat Apr 10 10:26:41 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2021-04-10 qun5feiyang

    为什么打不开

    0